Payments to Acquire Property, Plant, and Equipment of Axsome Therapeutics, Inc. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Axsome Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • Axsome Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $338,000, a 245% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $480,000, a 78% increase from 2024.
  • Axsome Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $270,000, a 54% decline from 2023.
  • Axsome Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $582,000, a 17% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Axsome Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $480,000 +$210,000 +78% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $270,000 -$312,000 -54% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $582,000 -$120,000 -17% 01 Jan 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
2022 $702,000 +$394,000 +128% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $308,000 +$262,109 +571% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $45,891 +$29,770 +185% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $16,121 -$16,575 -51% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $32,696 +$22,798 +230% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $9,898 -$94,663 -91% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $104,561 +$84,366 +418% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019 2018 FY
2015 $20,195 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2018 2017 FY

Axsome Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $338,000 +$240,000 +245% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $98,000 +$27,000 +38% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $71,000 -$143,000 -67% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $214,000 +$184,005 +613% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $29,995 +$20,664 +221% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022 2022 Q1
Q1 2020 $9,331 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2018 $14,576 +$11,677 +403% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $2,899 -$7,752 -73% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $10,651 +$395 +3.9% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $10,256 01 Jan 2015 31 Mar 2015 10-Q/A 09 Aug 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.